Cencora solution

Cell and gene therapy enablement

Building health system readiness and growth strategies for current and emerging cell and gene therapies (CGT).
Health system leaders planning a cell and gene therapy program.
Available for
  • Health systems
  • Pharmacies
  • Physician practices
Available in
  • U.S.
Related capabilities
  • Pharmacy solutions
  • Practice and clinic solutions
  • Hospital and health system solutions
Physician reviewing patient information in a clinical office

Preparing for the next phase of cell and gene therapy 

Physician reviewing patient information in a clinical office
Cell and gene therapy (CGT) is entering a new phase of growth, with the potential to transform what is possible for patients as therapies expand beyond early oncology into indications affecting larger patient populations. For health systems, that shift creates both opportunity and risk. Some organizations are evaluating whether to enter CGT for the first time. Others already administer CGT and need a more scalable, repeatable model to expand across therapies, sites, and service lines.

As part of Accelerate Pharmacy Solutions, CGT enablement helps health systems assess readiness, clarify financial and operational considerations, and plan for launch or expansion with greater confidence. By combining readiness assessment, financial modeling, governance design, and practical execution support, our team helps health systems reduce uncertainty, strengthen execution, and build a more repeatable foundation for long-term program growth - helping reduce barriers to care and expand patient access.

Physician reviewing patient information in a clinical office

How we help health systems prepare for sustainable CGT growth

Financial confidence

Make smarter cell and gene therapy decisions to enable patient access with a clearer view of market landscape, reimbursement, and financial risk before committing resources.
Adjust icon

Operational readiness

Launch with greater consistency and control by identifying critical gaps early and defining the governance, ownership model, and operating approach that fits your health system. 
computer analytics icon

Scalable growth

Expand with less disruption by building a stronger governance and operating foundation for performance, consistency, and growth across therapies, sites, and service lines.

Backed by deep CGT expertise and built specifically for health systems 

Practical and execution-focused
We help health systems move from assessment to action with support tailored to their priorities, readiness, and internal capacity.

Connected across key functions
We connect planning across pharmacy, patient access, finance, operations, and compliance to support more aligned decisions and more consistent execution.

Informed by Cencora upstream CGT experience¹
We bring broader CGT insight across consulting, market access, and specialty logistics to guide health system decisions. 

¹ Upstream CGT experience includes engagements across biopharma manufacturers, academic research, Contract Research Organizations, Contract Development and Manufacturing Organizations, and study sponsors. 

170
upstream CGT consulting projects completed across Cencora¹
29,000+
CGT shipments delivered annually across Cencora¹
30
U.S. Food and Drug Administration-approved CGTs supported across Cencora¹

Related resources

Article

Cell and gene therapy program implementation: Lessons from leading health systems
Learn more

Article

Cell and gene therapy integration: health system strategies for advancing patient care
Learn more

Article

CGT access: Managing risk at scale
Learn more
 

Connect with our team 

Whether your organization is evaluating cell and gene therapy for the first time or preparing for future growth, Accelerate Pharmacy Solutions can help your team assess readiness and plan for what comes next.